市場調査レポート

商品コード

1308576

心エコー（心臓超音波装置）市場の2030年までの予測：タイプ別、装置ディスプレイ別、技術別、エンドユーザー別、地域別の世界分析

Echocardiography Market Forecasts to 2030 - Global Analysis By Type, Device Display (CCD Colour Display and Black & White Display), Technology, End User and By Geography

出版日: 2023年07月01日
発行: Stratistics Market Research Consulting
ページ情報: 英文 175+ Pages
納期: 2～3営業日

カスタマイズ可能

価格

PDF (Single User License)

USD 4,150 617,935円

レポートPDFを1名様のみがご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは可能です。PDFの印刷は1回のみ可能です。印刷したもののご利用はPDFのご利用範囲に準拠します。

PDF (2-5 User License)

USD 5,250 781,725円

レポートPDFを同一事業所（所在地）内の5名までご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは可能です。PDFの印刷は5回まで可能です。印刷したもののご利用はPDFのご利用範囲に準拠します。

PDF & Excel (Site License)

USD 6,350 945,515円

レポートPDFおよびExcelを同一事業所（所在地）内のすべての方にご利用頂けるライセンスです。PDFおよびExcel内のテキスト等のコピーは可能です。PDFおよびExcelの印刷は5回まで可能です。印刷したもののご利用はPDFおよびExcelのご利用範囲に準拠します。

PDF & Excel (Global Site License)

USD 7,500 1,116,750円

レポートPDFおよびExcelを企業内すべての方に使用頂けるライセンスです。PDFおよびExcel内のテキスト等のコピーは可能です。PDFおよびExcelの印刷は10回まで可能です。印刷したもののご利用はPDFおよびExcelのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=148.90円

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

Stratistics MRCによると、世界の心エコー（心臓超音波装置）市場は2023年に19億米ドルを占め、予測期間中にCAGR 9.5％で成長し、2030年には35億米ドルに達する見込みです。

心エコーは、一般にエコーまたは心臓超音波装置として知られ、心血管疾患を探すために音波を使って心臓の画像を作成します。このツールを使うことで、血栓を見つけたり、心臓の室や弁を調べたりすることができます。経胸壁心エコー、経食道心エコー、および負荷心エコーは、さまざまな診断処置に利用される3つの異なる心臓超音波装置です。経胸壁心エコーは、その非侵襲的な性質から、心臓の問題を特定するために最も頻繁に利用される診断法です。

2022年に発表された英国心臓財団のデータによると、英国では約15億人が心房細動と診断されています。

市場力学：

促進要因

低侵襲心臓治療への需要の高まりと心臓病有病率の上昇

心臓病の罹患率が上昇し、侵襲性の低い心臓手術に対する需要が高まっています。また、ICEと他の画像モダリティを組み合わせた統合システムの開発や、画質の向上など心エコーシステムの技術開発が、市場の拡大をさらに促進すると予測されます。また、低侵襲心臓手術は痛みが少なく、入院期間が短く、回復が早いため、需要が高まっています。このような手術では、心臓にカテーテルやその他の器具を挿入する際のガイドとして心エコーが頻繁に利用されます。

抑制要因

熟練した専門家の不足

心エコーの使用には、専門的なトレーニングと専門知識が必要です。これらのシステムを操作できる熟練した専門家が不足しているため、導入が制限される可能性があります。さらに、経食道心エコー（TEE）や磁気共鳴画像法（MRI）などの代替画像技術があり、心エコーと市場シェアを争う可能性があります。

機会：

パルスドップラーの進歩による高解像度の心臓画像

心エコー市場では、ポータブル超音波検査への関心が高まっています。診断目的の心臓核医学検査は、心エコーとの大きな競合課題に直面しています。しかし、パルスドップラーの改良により、信頼性の高いプローブを食道に埋め込み、心臓画像の解像度を高めることが可能になりつつあります。心エコー業界の各社は、心筋と血液プールの内縁が交わるラインを特定し、追跡するのに役立つ音響定量化法の研究開発（R&D）に多くの投資を行っており、医師が心エコーを好むようになっています。

脅威

COVID-19の影響：

COVID-19期間中、市場は成長の鈍化を経験しました。心血管疾患の診断と治療のために診療所や病院を訪れる患者が減少し、緊急性のない処置が延期されたことが減少の原因となっています。2020年の世界市場は前年比8.3%減となっています。この間、COVID-19に関連しない診断手技は優先度が低いとみなされ、心血管疾患の検査件数が大幅に減少しました。

予測期間中、心腔内心エコーセグメントは最大となる見込み：

心腔内心エコーセグメントは、心臓内に挿入する小さな超音波プローブの使用により、心腔内心エコー（ICE）として知られる医療用画像処置で、心室、弁、静脈内の画像を生成できるため、有利な成長が見込まれます。この市場は、心臓疾患の発生率の増加、より低侵襲な心臓手術の必要性、ICEシステム技術の向上による精度の向上と使用率の向上といった理由によって活性化しています。

3D＆4D（3次元心エコー・4次元心エコー）セグメントは、予測期間中に最も高いCAGRが見込まれている：

3D＆4D（3次元心エコー・4次元心エコー）セグメントは、予測期間中にCAGRが最も高くなると予測されます。この技術には、画質の良さ、リアルな解剖学的画像、容積測定能力、中隔異常の確認能力などの特徴があり、このセグメントの成長に寄与しています。

最大のシェアを占める地域

北米は、新しく革新的な商品が広く受け入れられていること、利用可能な幅広い医療処置に関する知識が豊富であること、医療処置をサポートするインフラ投資が盛んであることから、予測期間中に最大の市場シェアを占めると予測されています。この地域の市場を促進するその他の重要な要因としては、ヘルスケアインフラや心エコー法の研究開発に対する政府の好意的な支援が挙げられます。

CAGRが最も高い地域：

アジア太平洋地域は、予測期間中に最も高いCAGRを示すと予測されます。これは、インドと中国における心血管疾患に罹患する膨大な人口に加え、アジア太平洋地域における未踏の可能性の存在と病状に対する意識の高まりが、市場の成長に寄与しているためです。喫煙、体重過多、血糖値上昇などのライフスタイル要因により、南アジア、インド、中国、オーストラリアでは心血管疾患のリスクが高いです。

主な発展：

2022年9月、Samsung Electronics Co., Ltd.はV7超音波システムの発売を発表しました。このシステムは、患者の心血管疾患の潜在的リスクを分析するためのAutoIMTツールを備えています。

2022年3月、Koninklijke Philips N.V.は、American College of Cardiology's Annual Scientific Session &Expo（ACC 2022）でUltrasound Workspaceの発売を発表しました。

2022年2月、Koninklijke Philips N.V.はハンドヘルド超音波診断装置Lumifyにパルスドップラー技術を追加しました。このアップデートは、同装置の血行動態評価および測定機能を拡張することを目的としています。

レポート内容

地域および国レベルセグメントの市場シェア評価
新規参入企業への戦略的提言
2021年、2022年、2023年、2026年、2030年の市場データをカバー
市場動向
市場推定に基づく主要ビジネスセグメントにおける戦略的提言
主要な一般的動向をマッピングした競合情勢
詳細な戦略、財務、最近の動向を含む企業プロファイル
最新の技術動向をマッピングしたサプライチェーン動向

無料カスタマイズサービス：

本レポートをご購読のお客様には、以下のいずれかの無料カスタマイズオプションをご提供いたします：

企業プロファイル
- 追加市場企業の包括的プロファイリング（3社まで）
- 主要企業のSWOT分析（3社まで）
地域セグメンテーション
- 顧客の関心に応じた主要国の市場推計・予測・CAGR（注：フィージビリティチェックによる）
競合ベンチマーキング
- 製品ポートフォリオ、地理的プレゼンス、戦略的提携に基づく主要企業のベンチマーキング

北米
- 米国
- カナダ
- メキシコ
欧州
- ドイツ
- 英国
- イタリア
- フランス
- スペイン
- その他欧州
アジア太平洋
- 日本
- 中国
- インド
- オーストラリア
- ニュージーランド
- 韓国
- その他アジア太平洋地域
南米
- アルゼンチン
- ブラジル
- チリ
- その他南米
中東・アフリカ
- サウジアラビア
- アラブ首長国連邦
- カタール
- 南アフリカ
- その他中東とアフリカ

第10章主な発展

契約、パートナーシップ、提携、合弁事業
買収と合併
新製品の上市
事業拡大
その他の主要戦略

第11章企業プロファイル

Siemens Healthcare GmbH
Conavi Medical
Boston Scientific Corporation
Abbott Laboratories
Koninklijke Philips NV
Goodman USA, Inc
Shifamed LLC（NuVera Medical）
Johnson & Johnson Services Inc.
Stereotaxis Inc.
GE Healthcare
B. Braun Melsungen AG
FUJIFILM Holdings Corporation
SAMSUNG ELECTRONICS Co., Ltd.
ESAOTE SPA
Meditronic
Terumo Corporation
St. Jude Medical

図表

List of Tables

Table 1 Global Echocardiography Market Outlook, By Region (2021-2030) ($MN)
Table 2 Global Echocardiography Market Outlook, By Type (2021-2030) ($MN)
Table 3 Global Echocardiography Market Outlook, By Transesophageal Echocardiography (2021-2030) ($MN)
Table 4 Global Echocardiography Market Outlook, By Transthoracic Echocardiography (2021-2030) ($MN)
Table 5 Global Echocardiography Market Outlook, By Stress Echocardiography (2021-2030) ($MN)
Table 6 Global Echocardiography Market Outlook, By Intracardiac Echocardiography (2021-2030) ($MN)
Table 7 Global Echocardiography Market Outlook, By Fetal Echocardiography (2021-2030) ($MN)
Table 8 Global Echocardiography Market Outlook, By Other Types (2021-2030) ($MN)
Table 9 Global Echocardiography Market Outlook, By Device Display (2021-2030) ($MN)
Table 10 Global Echocardiography Market Outlook, By Colour Display (2021-2030) ($MN)
Table 11 Global Echocardiography Market Outlook, By Black & White (B/W) Display (2021-2030) ($MN)
Table 12 Global Echocardiography Market Outlook, By Technology (2021-2030) ($MN)
Table 13 Global Echocardiography Market Outlook, By 2D (Two-Dimensional Echocardiography) (2021-2030) ($MN)
Table 14 Global Echocardiography Market Outlook, By 3D & 4D (Three-Dimensional Echocardiography & 4D Echocardiography) (2021-2030) ($MN)
Table 15 Global Echocardiography Market Outlook, By Doppler Imaging (2021-2030) ($MN)
Table 16 Global Echocardiography Market Outlook, By End User (2021-2030) ($MN)
Table 17 Global Echocardiography Market Outlook, By Diagnostic Center (2021-2030) ($MN)
Table 18 Global Echocardiography Market Outlook, By Hospitals (2021-2030) ($MN)
Table 19 Global Echocardiography Market Outlook, By Ambulatory/Home Care (2021-2030) ($MN)
Table 20 Global Echocardiography Market Outlook, By Pharmaceutical Companies (2021-2030) ($MN)
Table 21 Global Echocardiography Market Outlook, By Research Institutes (2021-2030) ($MN)
Table 22 Global Echocardiography Market Outlook, By Other End Users (2021-2030) ($MN)
Table 23 North America Echocardiography Market Outlook, By Country (2021-2030) ($MN)
Table 24 North America Echocardiography Market Outlook, By Type (2021-2030) ($MN)
Table 25 North America Echocardiography Market Outlook, By Transesophageal Echocardiography (2021-2030) ($MN)
Table 26 North America Echocardiography Market Outlook, By Transthoracic Echocardiography (2021-2030) ($MN)
Table 27 North America Echocardiography Market Outlook, By Stress Echocardiography (2021-2030) ($MN)
Table 28 North America Echocardiography Market Outlook, By Intracardiac Echocardiography (2021-2030) ($MN)
Table 29 North America Echocardiography Market Outlook, By Fetal Echocardiography (2021-2030) ($MN)
Table 30 North America Echocardiography Market Outlook, By Other Types (2021-2030) ($MN)
Table 31 North America Echocardiography Market Outlook, By Device Display (2021-2030) ($MN)
Table 32 North America Echocardiography Market Outlook, By Colour Display (2021-2030) ($MN)
Table 33 North America Echocardiography Market Outlook, By Black & White (B/W) Display (2021-2030) ($MN)
Table 34 North America Echocardiography Market Outlook, By Technology (2021-2030) ($MN)
Table 35 North America Echocardiography Market Outlook, By 2D (Two-Dimensional Echocardiography) (2021-2030) ($MN)
Table 36 North America Echocardiography Market Outlook, By 3D & 4D (Three-Dimensional Echocardiography & 4D Echocardiography) (2021-2030) ($MN)
Table 37 North America Echocardiography Market Outlook, By Doppler Imaging (2021-2030) ($MN)
Table 38 North America Echocardiography Market Outlook, By End User (2021-2030) ($MN)
Table 39 North America Echocardiography Market Outlook, By Diagnostic Center (2021-2030) ($MN)
Table 40 North America Echocardiography Market Outlook, By Hospitals (2021-2030) ($MN)
Table 41 North America Echocardiography Market Outlook, By Ambulatory/Home Care (2021-2030) ($MN)
Table 42 North America Echocardiography Market Outlook, By Pharmaceutical Companies (2021-2030) ($MN)
Table 43 North America Echocardiography Market Outlook, By Research Institutes (2021-2030) ($MN)
Table 44 North America Echocardiography Market Outlook, By Other End Users (2021-2030) ($MN)
Table 45 Europe Echocardiography Market Outlook, By Country (2021-2030) ($MN)
Table 46 Europe Echocardiography Market Outlook, By Type (2021-2030) ($MN)
Table 47 Europe Echocardiography Market Outlook, By Transesophageal Echocardiography (2021-2030) ($MN)
Table 48 Europe Echocardiography Market Outlook, By Transthoracic Echocardiography (2021-2030) ($MN)
Table 49 Europe Echocardiography Market Outlook, By Stress Echocardiography (2021-2030) ($MN)
Table 50 Europe Echocardiography Market Outlook, By Intracardiac Echocardiography (2021-2030) ($MN)
Table 51 Europe Echocardiography Market Outlook, By Fetal Echocardiography (2021-2030) ($MN)
Table 52 Europe Echocardiography Market Outlook, By Other Types (2021-2030) ($MN)
Table 53 Europe Echocardiography Market Outlook, By Device Display (2021-2030) ($MN)
Table 54 Europe Echocardiography Market Outlook, By Colour Display (2021-2030) ($MN)
Table 55 Europe Echocardiography Market Outlook, By Black & White (B/W) Display (2021-2030) ($MN)
Table 56 Europe Echocardiography Market Outlook, By Technology (2021-2030) ($MN)
Table 57 Europe Echocardiography Market Outlook, By 2D (Two-Dimensional Echocardiography) (2021-2030) ($MN)
Table 58 Europe Echocardiography Market Outlook, By 3D & 4D (Three-Dimensional Echocardiography & 4D Echocardiography) (2021-2030) ($MN)
Table 59 Europe Echocardiography Market Outlook, By Doppler Imaging (2021-2030) ($MN)
Table 60 Europe Echocardiography Market Outlook, By End User (2021-2030) ($MN)
Table 61 Europe Echocardiography Market Outlook, By Diagnostic Center (2021-2030) ($MN)
Table 62 Europe Echocardiography Market Outlook, By Hospitals (2021-2030) ($MN)
Table 63 Europe Echocardiography Market Outlook, By Ambulatory/Home Care (2021-2030) ($MN)
Table 64 Europe Echocardiography Market Outlook, By Pharmaceutical Companies (2021-2030) ($MN)
Table 65 Europe Echocardiography Market Outlook, By Research Institutes (2021-2030) ($MN)
Table 66 Europe Echocardiography Market Outlook, By Other End Users (2021-2030) ($MN)
Table 67 Asia Pacific Echocardiography Market Outlook, By Country (2021-2030) ($MN)
Table 68 Asia Pacific Echocardiography Market Outlook, By Type (2021-2030) ($MN)
Table 69 Asia Pacific Echocardiography Market Outlook, By Transesophageal Echocardiography (2021-2030) ($MN)
Table 70 Asia Pacific Echocardiography Market Outlook, By Transthoracic Echocardiography (2021-2030) ($MN)
Table 71 Asia Pacific Echocardiography Market Outlook, By Stress Echocardiography (2021-2030) ($MN)
Table 72 Asia Pacific Echocardiography Market Outlook, By Intracardiac Echocardiography (2021-2030) ($MN)
Table 73 Asia Pacific Echocardiography Market Outlook, By Fetal Echocardiography (2021-2030) ($MN)
Table 74 Asia Pacific Echocardiography Market Outlook, By Other Types (2021-2030) ($MN)
Table 75 Asia Pacific Echocardiography Market Outlook, By Device Display (2021-2030) ($MN)
Table 76 Asia Pacific Echocardiography Market Outlook, By Colour Display (2021-2030) ($MN)
Table 77 Asia Pacific Echocardiography Market Outlook, By Black & White (B/W) Display (2021-2030) ($MN)
Table 78 Asia Pacific Echocardiography Market Outlook, By Technology (2021-2030) ($MN)
Table 79 Asia Pacific Echocardiography Market Outlook, By 2D (Two-Dimensional Echocardiography) (2021-2030) ($MN)
Table 80 Asia Pacific Echocardiography Market Outlook, By 3D & 4D (Three-Dimensional Echocardiography & 4D Echocardiography) (2021-2030) ($MN)
Table 81 Asia Pacific Echocardiography Market Outlook, By Doppler Imaging (2021-2030) ($MN)
Table 82 Asia Pacific Echocardiography Market Outlook, By End User (2021-2030) ($MN)
Table 83 Asia Pacific Echocardiography Market Outlook, By Diagnostic Center (2021-2030) ($MN)
Table 84 Asia Pacific Echocardiography Market Outlook, By Hospitals (2021-2030) ($MN)
Table 85 Asia Pacific Echocardiography Market Outlook, By Ambulatory/Home Care (2021-2030) ($MN)
Table 86 Asia Pacific Echocardiography Market Outlook, By Pharmaceutical Companies (2021-2030) ($MN)
Table 87 Asia Pacific Echocardiography Market Outlook, By Research Institutes (2021-2030) ($MN)
Table 88 Asia Pacific Echocardiography Market Outlook, By Other End Users (2021-2030) ($MN)
Table 89 South America Echocardiography Market Outlook, By Country (2021-2030) ($MN)
Table 90 South America Echocardiography Market Outlook, By Type (2021-2030) ($MN)
Table 91 South America Echocardiography Market Outlook, By Transesophageal Echocardiography (2021-2030) ($MN)
Table 92 South America Echocardiography Market Outlook, By Transthoracic Echocardiography (2021-2030) ($MN)
Table 93 South America Echocardiography Market Outlook, By Stress Echocardiography (2021-2030) ($MN)
Table 94 South America Echocardiography Market Outlook, By Intracardiac Echocardiography (2021-2030) ($MN)
Table 95 South America Echocardiography Market Outlook, By Fetal Echocardiography (2021-2030) ($MN)
Table 96 South America Echocardiography Market Outlook, By Other Types (2021-2030) ($MN)
Table 97 South America Echocardiography Market Outlook, By Device Display (2021-2030) ($MN)
Table 98 South America Echocardiography Market Outlook, By Colour Display (2021-2030) ($MN)
Table 99 South America Echocardiography Market Outlook, By Black & White (B/W) Display (2021-2030) ($MN)
Table 100 South America Echocardiography Market Outlook, By Technology (2021-2030) ($MN)
Table 101 South America Echocardiography Market Outlook, By 2D (Two-Dimensional Echocardiography) (2021-2030) ($MN)
Table 102 South America Echocardiography Market Outlook, By 3D & 4D (Three-Dimensional Echocardiography & 4D Echocardiography) (2021-2030) ($MN)
Table 103 South America Echocardiography Market Outlook, By Doppler Imaging (2021-2030) ($MN)
Table 104 South America Echocardiography Market Outlook, By End User (2021-2030) ($MN)
Table 105 South America Echocardiography Market Outlook, By Diagnostic Center (2021-2030) ($MN)
Table 106 South America Echocardiography Market Outlook, By Hospitals (2021-2030) ($MN)
Table 107 South America Echocardiography Market Outlook, By Ambulatory/Home Care (2021-2030) ($MN)
Table 108 South America Echocardiography Market Outlook, By Pharmaceutical Companies (2021-2030) ($MN)
Table 109 South America Echocardiography Market Outlook, By Research Institutes (2021-2030) ($MN)
Table 110 South America Echocardiography Market Outlook, By Other End Users (2021-2030) ($MN)
Table 111 Middle East & Africa Echocardiography Market Outlook, By Country (2021-2030) ($MN)
Table 112 Middle East & Africa Echocardiography Market Outlook, By Type (2021-2030) ($MN)
Table 113 Middle East & Africa Echocardiography Market Outlook, By Transesophageal Echocardiography (2021-2030) ($MN)
Table 114 Middle East & Africa Echocardiography Market Outlook, By Transthoracic Echocardiography (2021-2030) ($MN)
Table 115 Middle East & Africa Echocardiography Market Outlook, By Stress Echocardiography (2021-2030) ($MN)
Table 116 Middle East & Africa Echocardiography Market Outlook, By Intracardiac Echocardiography (2021-2030) ($MN)
Table 117 Middle East & Africa Echocardiography Market Outlook, By Fetal Echocardiography (2021-2030) ($MN)
Table 118 Middle East & Africa Echocardiography Market Outlook, By Other Types (2021-2030) ($MN)
Table 119 Middle East & Africa Echocardiography Market Outlook, By Device Display (2021-2030) ($MN)
Table 120 Middle East & Africa Echocardiography Market Outlook, By Colour Display (2021-2030) ($MN)
Table 121 Middle East & Africa Echocardiography Market Outlook, By Black & White (B/W) Display (2021-2030) ($MN)
Table 122 Middle East & Africa Echocardiography Market Outlook, By Technology (2021-2030) ($MN)
Table 123 Middle East & Africa Echocardiography Market Outlook, By 2D (Two-Dimensional Echocardiography) (2021-2030) ($MN)
Table 124 Middle East & Africa Echocardiography Market Outlook, By 3D & 4D (Three-Dimensional Echocardiography & 4D Echocardiography) (2021-2030) ($MN)
Table 125 Middle East & Africa Echocardiography Market Outlook, By Doppler Imaging (2021-2030) ($MN)
Table 126 Middle East & Africa Echocardiography Market Outlook, By End User (2021-2030) ($MN)
Table 127 Middle East & Africa Echocardiography Market Outlook, By Diagnostic Center (2021-2030) ($MN)
Table 128 Middle East & Africa Echocardiography Market Outlook, By Hospitals (2021-2030) ($MN)
Table 129 Middle East & Africa Echocardiography Market Outlook, By Ambulatory/Home Care (2021-2030) ($MN)
Table 130 Middle East & Africa Echocardiography Market Outlook, By Pharmaceutical Companies (2021-2030) ($MN)
Table 131 Middle East & Africa Echocardiography Market Outlook, By Research Institutes (2021-2030) ($MN)
Table 132 Middle East & Africa Echocardiography Market Outlook, By Other End Users (2021-2030) ($MN)

Product Code: SMRC23291

According to Stratistics MRC, the Global Echocardiography Market is accounted for $1.9 billion in 2023 and is expected to reach $3.5 billion by 2030 growing at a CAGR of 9.5% during the forecast period. Echocardiography, commonly known as an echo or cardiac ultrasound, creates images of the heart using sound waves in order to look for any cardiovascular illness. With the use of this tool, blood clots may be found and the chambers and valves of the heart can be studied. Transthoracic, transesophageal, and stress cardiac ultrasonography are three different cardiac ultrasound examinations that are utilised for various diagnostic procedures. Due to its non-invasive nature, transthoracic cardiac ultrasonography is the most often utilised diagnostic procedure for identifying heart problems.

According to the British Heart Foundation data published in 2022, around 1.5 billion people in the U.K. have been diagnosed with atrial fibrillation.

Market Dynamics:

Driver:

Growing demand for minimally invasive cardiac treatments and rising prevalence of heart disease

The rising incidence of heart disease and the rising demand for less invasive cardiac operations. Additionally, the development of integrated systems that combine ICE with other imaging modalities and technological developments in echocardiography systems, such as enhanced picture quality, are anticipated to further propel market expansion. Additionally there is an increasing demand for minimally invasive cardiac operations since they are less painful, require fewer hospital stays, and have quicker recovery times. During these surgeries, echocardiography is frequently utilised as a guide for inserting catheters and other devices into the heart.

Restraint:

Lack of skilled professionals

The use of echocardiography requires specialized training and expertise. The shortage of skilled professionals who can operate these systems may limit its adoption. Moreover there are alternative imaging techniques, such as transesophageal echocardiography (TEE) and magnetic resonance imaging (MRI), which may compete with echocardiography for market share.

Opportunity:

Pulse doppler advances deliver high resolution heart images

The market for echocardiography is seeing an increase in interest in the idea of portable ultrasound. Nuclear cardiology for diagnostic purposes faces a significant competitive challenge from echocardiography. However, improvements in pulse doppler are making it possible to implant trustworthy probes into the oesophagus to increase the resolution of cardiac imaging. Companies in the echocardiography industry are investing more in research and development (R&D) for acoustic quantification methods that aid in identifying and keeping track of the line where the inner margin of the myocardium and blood pool meets is encouraging the doctors to much prefer echocardiography.

Threat:

Associated Limitations

Portable cardiac ultrasonography equipment has several restrictions. Despite being smaller in size, they have a smaller screen, which may affect the diagnosis. With fewer ultrasonic frequencies, the resolution is poorer, and the image optimisation is subpar. Additionally, they may only use 2D pictures. As a result, the bulk and expensive price of these gadgets may prevent widespread use in the years to come.

COVID-19 Impact:

During COVID-19, the market experienced a decline in its growth. Fewer patients visiting the clinics and hospitals for cardiovascular disease diagnosis and treatment and the postponement of non-emergency procedures were responsible for the decline. The global market experienced a decline of 8.3% in 2020 as compared to the past year. During this period, non-COVID-19-related diagnostic procedures were considered low-priority, which caused a significant decrease in the testing volume of cardiovascular disorders.

The Intracardiac Echocardiography segment is expected to be the largest during the forecast period:

The Intracardiac Echocardiography segment is estimated to have a lucrative growth, due to the use of a tiny ultrasonic probe that is put within the heart, a medical imaging procedure known as intracardiac echocardiography (ICE) can produce pictures of the heart's chambers, valves, and blood veins. The market is fuelled by reasons such the increased incidence of heart illness, the need for less invasive cardiac operations, and improvements in ICE system technology that increase its accuracy and use.

The 3D & 4D (Three-Dimensional Echocardiography & 4DEchocardiography) segment is expected to have the highest CAGR during the forecast period:

The 3D & 4D (Three-Dimensional Echocardiography & 4DEchocardiography) segment is anticipated to witness the highest CAGR growth during the forecast period, due to The characteristics of this technology, including as good picture quality, realistic anatomical images, the capacity to offer volume measurement, and the ability to see septal abnormalities, have contributed to the segment's rise.

Region with largest share:

North America is projected to hold the largest market share during the forecast period owing to widespread acceptance of new and innovative goods, great knowledge of the range of medical treatments available, and major infrastructure investment supporting medical treatments. Other significant drivers propelling the market in the area include favourable government assistance for healthcare infrastructure and research and development of echocardiography.

Region with highest CAGR:

Asia Pacific is projected to have the highest CAGR over the forecast period, owing to the vast population suffering from cardiovascular illnesses in India and China, combined with the presence of unexplored potential and increased awareness of medical conditions in Asia Pacific, all contribute to the market's growth. Due to lifestyle factors including smoking, excessive weight, and elevated blood sugar levels, the risk of cardiovascular disease is higher in South Asia, India, China, and Australia.

Key players in the market

Some of the key players profiled in the Echocardiography Market include Siemens Healthcare GmbH, Conavi Medical, Boston Scientific Corporation, Abbott Laboratories, Koninklijke Philips NV, Goodman USA, Inc, Shifamed LLC (NuVera Medical), Johnson & Johnson Services Inc., Stereotaxis Inc., GE Healthcare, B. Braun Melsungen AG, FUJIFILM Holdings Corporation, SAMSUNG ELECTRONICS Co., Ltd, ESAOTE SPA, Meditronic, Terumo Corporation and St. Jude Medical

Key Developments:

In September 2022, Samsung Electronics Co., Ltd. announced the launch of V7 ultrasound system. The system possesses AutoIMT tool for analyzing a patient's potential risk for cardiovascular disease.

In March 2022, Koninklijke Philips N.V. announced the launch of Ultrasound Workspace at the American College of Cardiology's Annual Scientific Session & Expo (ACC 2022).

In February 2022, Koninklijke Philips N.V. added Pulse Wave Doppler technology to Lumify, a handheld ultrasound device. The update aims to expand the hemodynamic assessment and measurement capabilities of the system.

Types Covered:

Transesophageal Echocardiography
Transthoracic Echocardiography
Stress Echocardiography
Intracardiac Echocardiography
Fetal Echocardiography
Other Types

Device Displays Covered:

Colour Display
Black & White (B/W) Display

Technologies Covered:

2D (Two-Dimensional Echocardiography)
3D & 4D (Three-Dimensional Echocardiography & 4D Echocardiography)
Doppler Imaging

End Users Covered:

Diagnostic Center
Hospitals
Ambulatory/Home Care
Pharmaceutical Companies
Research Institutes
Other End Users

Regions Covered:

North America
- US
- Canada
- Mexico
Europe
- Germany
- UK
- Italy
- France
- Spain
- Rest of Europe
Asia Pacific
- Japan
- China
- India
- Australia
- New Zealand
- South Korea
- Rest of Asia Pacific
South America
- Argentina
- Brazil
- Chile
- Rest of South America
Middle East & Africa
- Saudi Arabia
- UAE
- Qatar
- South Africa
- Rest of Middle East & Africa

What our report offers:

Market share assessments for the regional and country-level segments
Strategic recommendations for the new entrants
Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
Strategic recommendations in key business segments based on the market estimations
Competitive landscaping mapping the key common trends
Company profiling with detailed strategies, financials, and recent developments
Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

Company Profiling
- Comprehensive profiling of additional market players (up to 3)
- SWOT Analysis of key players (up to 3)
Regional Segmentation
- Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
Competitive Benchmarking
- Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

1 Executive Summary

2 Preface

2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
- 2.4.1 Data Mining
- 2.4.2 Data Analysis
- 2.4.3 Data Validation
- 2.4.4 Research Approach
2.5 Research Sources
- 2.5.1 Primary Research Sources
- 2.5.2 Secondary Research Sources
- 2.5.3 Assumptions

3 Market Trend Analysis

3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Technology Analysis
3.7 End User Analysis
3.8 Emerging Markets
3.9 Impact of Covid-19

4 Porters Five Force Analysis

4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry

5 Global Echocardiography Market, By Type

5.1 Introduction
5.2 Transesophageal Echocardiography
5.3 Transthoracic Echocardiography
5.4 Stress Echocardiography
5.5 Intracardiac Echocardiography
5.6 Fetal Echocardiography
5.7 Other Types

6 Global Echocardiography Market, By Device Display

6.1 Introduction
6.2 Colour Display
6.3 Black & White (B/W) Display

7 Global Echocardiography Market, By Technology

7.1 Introduction
7.2 2D (Two-Dimensional Echocardiography)
7.3 3D & 4D (Three-Dimensional Echocardiography & 4D Echocardiography)
7.4 Doppler Imaging

8 Global Echocardiography Market, By End User

8.1 Introduction
8.2 Diagnostic Center
8.3 Hospitals
8.4 Ambulatory/Home Care
8.5 Pharmaceutical Companies
8.6 Research Institutes
8.7 Other End Users

9 Global Echocardiography Market, By Geography

9.1 Introduction
9.2 North America
- 9.2.1 US
- 9.2.2 Canada
- 9.2.3 Mexico
9.3 Europe
- 9.3.1 Germany
- 9.3.2 UK
- 9.3.3 Italy
- 9.3.4 France
- 9.3.5 Spain
- 9.3.6 Rest of Europe
9.4 Asia Pacific
- 9.4.1 Japan
- 9.4.2 China
- 9.4.3 India
- 9.4.4 Australia
- 9.4.5 New Zealand
- 9.4.6 South Korea
- 9.4.7 Rest of Asia Pacific
9.5 South America
- 9.5.1 Argentina
- 9.5.2 Brazil
- 9.5.3 Chile
- 9.5.4 Rest of South America
9.6 Middle East & Africa
- 9.6.1 Saudi Arabia
- 9.6.2 UAE
- 9.6.3 Qatar
- 9.6.4 South Africa
- 9.6.5 Rest of Middle East & Africa

10 Key Developments

10.1 Agreements, Partnerships, Collaborations and Joint Ventures
10.2 Acquisitions & Mergers
10.3 New Product Launch
10.4 Expansions
10.5 Other Key Strategies

11 Company Profiling

11.1 Siemens Healthcare GmbH
11.2 Conavi Medical
11.3 Boston Scientific Corporation
11.4 Abbott Laboratories
11.5 Koninklijke Philips NV
11.6 Goodman USA, Inc
11.7 Shifamed LLC (NuVera Medical)
11.8 Johnson & Johnson Services Inc.
11.9 Stereotaxis Inc.
11.10 GE Healthcare
11.11 B. Braun Melsungen AG
11.12 FUJIFILM Holdings Corporation
11.13 SAMSUNG ELECTRONICS Co., Ltd.
11.14 ESAOTE SPA
11.15 Meditronic
11.16 Terumo Corporation
11.17 St. Jude Medical